Diag-Nose
Read time: 2 mins
By Samuel Wines
31 January 2025
Founded in 2020, Diag-Nose.io is revolutionising respiratory healthcare by decoding the intricate mechanisms of the unified airway (the interconnected relationship between our lungs and nasal passages). By leveraging advanced proteomics, computational biology, and AI-driven biomarkers, their flagship platform, RhinoMAP™, enables clinicians to prescribe tailored treatments swiftly and empowers researchers to accelerate the development of new therapies.
Committed to building the future of respiratory care, Diag-Nose.io is developing the most comprehensive human dataset for precision respiratory medicine, bridging the gap between diagnostics and treatment to improve patient outcomes worldwide.
Curious to know more? Check them out here:
Check them out in the news, too!